Computer Systems Validation

  • Subscribe to our RSS feed.
  • Twitter
  • StumbleUpon
  • Reddit
  • Facebook
  • Digg

Monday, 31 May 2010

What is a risk based approach?

Posted on 07:47 by Unknown
As discussed in a previous article (Changes in Validation) a risk based approach to computer systems validation has change the way validation is performed.

Spend LessMany in the pharmaceutical and biotech industries miss understood the message of a Risk Based Approach as an opportunity to take quality risk and spend less on the introduction of new equipment; that is to take a risk.

However this
Read More
Posted in Quality Risk Management, Validation | No comments

Wednesday, 26 May 2010

CSV FDA Warning Letters : Audit Trail

Posted on 12:31 by Unknown
Date: 14 January 2010
Link: FDA Warning Letter (New Window)

Observation6. Your firm has not exercised appropriate controls over computer or related systems to assure that changes in master production and control records or other records are instituted only by authorized personnel [21 CFR 211.68(b)].

For example, your firm lacks systems to ensure that all electronic data generated in your
Read More
Posted in FDA Warning Letters | No comments

Monday, 24 May 2010

CSV FDA Warning Letters : Operational Compliance

Posted on 11:11 by Unknown
Date: 21 December 2009
Link: FDA Warning Letter (New Window)

Observation19. Automatic, mechanical, or electronic equipment is not routinely calibrated, inspected, or checked according to a written program designed to assure proper performance [21 CFR 211.68(a)]. For instance, the mixer, scales, filling/dispensing machine, water distiller, foil heat sealing machine, drying chamber, and tablet
Read More
Posted in FDA Warning Letters | No comments

Friday, 21 May 2010

CSV FDA Warning Letters : Qualification

Posted on 11:38 by Unknown
Date: 27 April 2009
Link: FDA Warning Letter (New Window)

Observation8. Failure to maintain a written record and appropriate validation data of computer or other automated processes used to perform calculations in connection with laboratory analysis [21 CFR 211.68(b)]. Refer to FDA 483, Observation 12. For example, the accuracy of calculations performed by the [(b)(4)] Spectrophotometer has not
Read More
Posted in FDA Warning Letters | No comments

Thursday, 20 May 2010

CSV FDA Warning Letters : Security

Posted on 10:26 by Unknown
Date: 07 May 2009
Link: FDA Warning Letter (New Window)

Observation5. Your firm has not exercised appropriate controls over computer or related systems to assure that changes in control records or other records are instituted only by authorized personnel [21 CFR 211.68(b)J. For example, one user account is established for two analysts to access the laboratory instrument's software on the
Read More
Posted in FDA Warning Letters | No comments

Wednesday, 19 May 2010

CSV FDA Warning Letters : ERP and Calibration

Posted on 10:23 by Unknown
Date: 07 May 2009
Link: FDA Warning Letter (New Window)

Observation4. Failure to routinely calibrate, inspect, or check according to a written program designed to assure proper performance of automatic, mechanical, or electronic equipment, including computers, used in the manufacture, processing, packing and holding of a drug product. [21 CFR 211.68]

Part A
A. The Enterprise Resource Planning
Read More
Posted in FDA Warning Letters | No comments

Tuesday, 18 May 2010

CSV FDA Warning Letters : Qualification

Posted on 11:10 by Unknown
Date: 08 April 2010
Link: FDA Warning Letter (New Window)

Observation7. Your firm failed to routinely calibrate, inspect, or check automatic, mechanical, or electronic equipment according to a written program designed to assure proper performance [21 C.F.R. § 211.68(a)].
For example, your firm has not conducted performance qualification for the (b)(4) unit-dose packaging machine (b)(4)™ to
Read More
Posted in FDA Warning Letters | No comments

Monday, 17 May 2010

Computer System Impact / Risk Assessment

Posted on 13:21 by Unknown
Purpose of Risk AssessmentThe purpose of the risk assessment process is to ensure that the validation (quality) effort is directed at the systems that have the potential to impact product quality, efficacy and data integrity (throughout this article referred to as Product Quality).
Initial Risk AssessmentsIn the ISPE Commissioning and Qualification Guide the approach to an initial impact
Read More
Posted in GAMP 5, Quality Risk Management | No comments

Wednesday, 12 May 2010

FDA to Increase Inspections in 2010

Posted on 12:53 by Unknown
The US Food and Drugs Administration (FDA) have been given a significant budget increase for 2010 as reported on Congresswoman Rosa DeLauro web site.


Introduced by Rep. Rosa DeLauro (D-CT), the bill (H.R. 2997) provides the amount that President Obama requested for the agency, which is roughly $373 million more than the FDA’s budget for fiscal 2009 (15% increase).

The funds will help the FDA
Read More
Posted in FDA News | No comments

Tuesday, 11 May 2010

MHRA Inspection Trends

Posted on 23:00 by Unknown
Unlike the US Food and Drugs Administration (FDA) the Medicines and Healthcare products Regulatory Agency (MHRA) do not publish individual findings however they have published inspection trends.

The result of the trends shows that Computer Systems Validation has a number of Major Observations. Comments or observations from the trended data are welcome.

Link to MHRA Inspection Trends
Read More
Posted in MHRA | No comments

Efficient Software Testing

Posted on 10:00 by Unknown
Testing, as with all validation activities, is not only performed to demonstrate regulatory compliance but to ensure that the system operates correctly.

The level of testing performed should be dependant on the complexity, maturity and criticality of the system.

A standard laboratory instrument should not need the same level of testing as a bespoke automated control system. This is where the
Read More
Posted in GAMP 5, Testing, Validation | No comments

ISPE GAMP5

Posted on 08:34 by Unknown
GAMP 5 was released in 2008 detailing “Risk Based Approach to Compliant GxP Computerised Systems” with the tag line “Enabling Innovation” and was hailed as a major advancement in the industry.

This article provides a short review of the GAMP guide and the benefits to the industry.

ASTM StandardThe publishing of the ASTM Standard E2500-07 in June 2007 set the scene for
Read More
Posted in GAMP 5 | No comments

GAMP5 Software Categories

Posted on 08:17 by Unknown
As discussed in ISPE GAMP 5 the GAMP Categories for hardware and software have been retained in GAMP 5, all be it in a modified format from GAMP4.

The software categories identified in GAMP 5 do not fit with determining the risk to product quality, efficacy or data integrity and no longer plays an integral part to determining that a computer system is fit for purpose.

The complexity and the
Read More
Posted in ASTM-2500, GAMP 5, Validation | No comments

Changes in validation

Posted on 06:24 by Unknown
There have been many changes to the approach to validation of equipment, including computerised systems over the last few years. This has culminated in the release of GAMP 5 in 2008.

The changes in approach started with the publication of the ICH Q9 (Quality Risk Management) in 2005 and adopted by the major agencies. This presented a risk based approach to quality management including validation
Read More
Posted in GAMP 5, Quality Assurance, Validation | No comments
Newer Posts Home
Subscribe to: Comments (Atom)

Popular Posts

  • Applying Computer System Security (GAMP)
    It is a regulatory requirement that access to computerised systems is limited to authorised users. This not only limited to systems that con...
  • Deleting Electronic Data
    Hybrid Systems (Deleting Electronic Data) In Hybrid systems the computerised system is used to generate a record which is printed and hand s...
  • CSV FDA Warning Letter : Periodic Review
    Date: 21 May 2010 Link: FDA Warning Letter (New Window) Observation6. Your firm failed to check the accuracy of the input to and output from...
  • FDA Announce Part 21 CFR 11 Inspections
    Image via WikipediaAs detailed within the post 21 CFR Part 11 Warning Letters the FDA are planning to start conducting part 11 inspections s...
  • Spreadsheet Validation
    Spreadsheets have become commonly used within a wide range of applications within the pharmaceutical and biotechnology industries. These ran...
  • Software Validation
    The validation of computer software within the Pharmaceutical Industry is providing documented evidence that the software and computer syste...
  • CSV Periodic Review
    Regulatory requirement Both the FDA and EU GMP’s detail the requirement for demonstrating that a computer system remains in a validated stat...
  • CSV FDA Warning Letters : Laboratory Systems Security
    Date: 20 April 2010 Link: FDA Warning Letter (New Window) ObservationThis is a follow up letter from an inspection in 2009 where the securit...
  • Risk Management – A Continuous Process
    Introduction As discussed in previous posts the regulatory expectation is that risk management will be applied to all lifecycle phases of a ...
  • FDA Warning Letter - Alarm Management
    Date: 25 May 11 Link FDA 483 (PDF - New Window) Observation b. During routine operations, if there is an alarm event (e.g., time out, high a...

Categories

  • 21 CFR Part 11
  • ASTM-2500
  • Electronic Records
  • EU Annex 11
  • FDA News
  • FDA Warning Letters
  • GAMP 5
  • MHRA
  • Quality Assurance
  • Quality Risk Management
  • Spreadsheets
  • Supplier Audit
  • Testing
  • Validation

Blog Archive

  • ►  2012 (6)
    • ►  November (1)
    • ►  August (1)
    • ►  July (1)
    • ►  April (1)
    • ►  February (1)
    • ►  January (1)
  • ►  2011 (14)
    • ►  December (2)
    • ►  September (1)
    • ►  May (1)
    • ►  April (3)
    • ►  March (3)
    • ►  February (4)
  • ▼  2010 (26)
    • ►  December (2)
    • ►  August (1)
    • ►  July (2)
    • ►  June (7)
    • ▼  May (14)
      • What is a risk based approach?
      • CSV FDA Warning Letters : Audit Trail
      • CSV FDA Warning Letters : Operational Compliance
      • CSV FDA Warning Letters : Qualification
      • CSV FDA Warning Letters : Security
      • CSV FDA Warning Letters : ERP and Calibration
      • CSV FDA Warning Letters : Qualification
      • Computer System Impact / Risk Assessment
      • FDA to Increase Inspections in 2010
      • MHRA Inspection Trends
      • Efficient Software Testing
      • ISPE GAMP5
      • GAMP5 Software Categories
      • Changes in validation
Powered by Blogger.

About Me

Unknown
View my complete profile